| Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial RECOVERY Collaborative Group Lancet (London, England) 397 (10285), 1637, 2021 | 2466* | 2021 |
| SARS-CoV-2 Omicron-B. 1.1. 529 leads to widespread escape from neutralizing antibody responses W Dejnirattisai, J Huo, D Zhou, J Zahradník, P Supasa, C Liu, ... Cell 185 (3), 467-484. e15, 2022 | 957 | 2022 |
| Mapping the human genetic architecture of COVID-19 Writing group Writing group leaders Pathak Gita A. 6 Andrews Shea J. 7 Kanai ... Nature 600 (7889), 472-477, 2021 | 775 | 2021 |
| D614G spike mutation increases SARS CoV-2 susceptibility to neutralization D Weissman, MG Alameh, T de Silva, P Collini, H Hornsby, R Brown, ... Cell host & microbe 29 (1), 23-31. e4, 2021 | 372 | 2021 |
| Co-infections, secondary infections, and antimicrobial use in patients hospitalised with COVID-19 during the first pandemic wave from the ISARIC WHO CCP-UK study: a multicentre … CD Russell, CJ Fairfield, TM Drake, L Turtle, RA Seaton, DG Wootton, ... The Lancet Microbe 2 (8), e354-e365, 2021 | 318 | 2021 |
| Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis O Abani, A Abbas, F Abbas, J Abbas, K Abbas, M Abbas, S Abbasi, ... The Lancet 400 (10349), 359-368, 2022 | 252 | 2022 |
| Development and validation of the ISARIC 4C Deterioration model for adults hospitalised with COVID-19: a prospective cohort study RK Gupta, EM Harrison, A Ho, AB Docherty, SR Knight, M van Smeden, ... The Lancet Respiratory Medicine 9 (4), 349-359, 2021 | 227 | 2021 |
| Risk of adverse outcomes in patients with underlying respiratory conditions admitted to hospital with COVID-19: a national, multicentre prospective cohort study using the … CI Bloom, TM Drake, AB Docherty, BJ Lipworth, SL Johnston, ... The Lancet Respiratory Medicine 9 (7), 699-711, 2021 | 177 | 2021 |
| Characterisation of in-hospital complications associated with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol UK: a prospective, multicentre cohort study TM Drake, AM Riad, CJ Fairfield, C Egan, SR Knight, R Pius, ... The Lancet 398 (10296), 223-237, 2021 | 155 | 2021 |
| Changes in in-hospital mortality in the first wave of COVID-19: a multicentre prospective observational cohort study using the WHO Clinical Characterisation Protocol UK AB Docherty, RH Mulholland, NI Lone, CP Cheyne, D De Angelis, ... The Lancet Respiratory Medicine 9 (7), 773-785, 2021 | 103 | 2021 |
| Impaired mitochondrial microbicidal responses in chronic obstructive pulmonary disease macrophages MA Bewley, JA Preston, M Mohasin, HM Marriott, RC Budd, J Swales, ... American journal of respiratory and critical care medicine 196 (7), 845-855, 2017 | 101 | 2017 |
| Non-steroidal anti-inflammatory drug use and outcomes of COVID-19 in the ISARIC Clinical Characterisation Protocol UK cohort: a matched, prospective cohort study TM Drake, CJ Fairfield, R Pius, SR Knight, L Norman, M Girvan, ... The Lancet Rheumatology 3 (7), e498-e506, 2021 | 88 | 2021 |
| Comparison of 3He and 129Xe MRI for evaluation of lung microstructure and ventilation at 1.5T NJ Stewart, HF Chan, PJC Hughes, FC Horn, G Norquay, M Rao, ... Journal of magnetic resonance imaging 48 (3), 632-642, 2018 | 83 | 2018 |
| SARS-CoV-2-specific nasal IgA wanes 9 months after hospitalisation with COVID-19 and is not induced by subsequent vaccination F Liew, S Talwar, A Cross, BJ Willett, S Scott, N Logan, MK Siggins, ... EBioMedicine 87, 2023 | 79 | 2023 |
| Clostridium difficile infection in HIV-seropositive individuals and transplant recipients PJ Collini, M Bauer, E Kuijper, DH Dockrell Journal of Infection 64 (2), 131-147, 2012 | 73 | 2012 |
| Opsonic phagocytosis in chronic obstructive pulmonary disease is enhanced by Nrf2 agonists MA Bewley, RC Budd, E Ryan, J Cole, P Collini, J Marshall, U Kolsum, ... American journal of respiratory and critical care medicine 198 (6), 739-750, 2018 | 65 | 2018 |
| The impact of viral mutations on recognition by SARS-CoV-2 specific T cells TI de Silva, G Liu, BB Lindsey, D Dong, SC Moore, NS Hsu, D Shah, ... Iscience 24 (11), 2021 | 63 | 2021 |
| Monocyte and macrophage dysfunction as a cause of HIV-1 induced dysfunction of innate immunity P Collini, M Noursadeghi, I Sabroe, R F Miller, D H Dockrell Current Molecular Medicine 10 (8), 727-740, 2010 | 54 | 2010 |
| Worldwide relative smoking prevalence among people living with and without HIV PI Johnston, SW Wright, M Orr, FA Pearce, JW Stevens, RB Hubbard, ... Aids 35 (6), 957-970, 2021 | 48 | 2021 |
| Community-acquired pneumonia: doctors do not follow national guidelines P Collini, M Beadsworth, J Anson, T Neal, P Burnham, P Deegan, ... Postgraduate medical journal 83 (982), 552-555, 2007 | 45 | 2007 |
